These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10695992)

  • 1. Absence of p51 mutation in human hepatocellular carcinoma.
    Hamada K; Koyama T; Shimizu K; Ikawa S; Kawate S; Yokota J; Ohwada S; Morishita Y
    Cancer Lett; 2000 Feb; 148(2):161-4. PubMed ID: 10695992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of p51 alteration in human ovarian cancer.
    Shinozaki H; Okamoto A; Shimizu K; Saito M; Yokota J; Ochiai K
    Int J Oncol; 2001 Mar; 18(3):549-52. PubMed ID: 11179485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analysis of the p51 gene and correlation between p53, p73, and p51 expressions in prostatic carcinoma.
    Takahashi H; Fukutome K; Watanabe M; Furusato M; Shiraishi T; Ito H; Suzuki H; Ikawa S; Hano H
    Prostate; 2001 May; 47(2):85-90. PubMed ID: 11340630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation and expression of the p51 gene in human lung cancer.
    Tani M; Shimizu K; Kawahara C; Kohno T; Ishimoto O; Ikawa S; Yokota J
    Neoplasia; 1999 Apr; 1(1):71-9. PubMed ID: 10935472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of the p51/p63 gene is associated with blastic crisis in chronic myelogenous leukemia.
    Yamaguchi H; Inokuchi K; Sakuma Y; Dan K
    Leukemia; 2001 Nov; 15(11):1729-34. PubMed ID: 11681414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation and transcription analyses of the p63 gene in cervical carcinoma.
    Nishi H; Isaka K; Sagawa Y; Usuda S; Fujito A; Ito H; Senoo M; Kato H; Takayama M
    Int J Oncol; 1999 Dec; 15(6):1149-53. PubMed ID: 10568821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational analysis of p51A/TAp63gamma, a p53 homolog, in non-small cell lung cancer and breast cancer.
    Sunahara M; Shishikura T; Takahashi M; Todo S; Yamamoto N; Kimura H; Kato S; Ishioka C; Ikawa S; Ikawa Y; Nakagawara A
    Oncogene; 1999 Jun; 18(25):3761-5. PubMed ID: 10391684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of p33(ING1b) and p53 gene expression in hepatocellular carcinoma].
    Zhu Z; Zhu M; Ni C
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(19):1332-6. PubMed ID: 12509938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of p53 gene expression in human primary hepatocellular carcinoma is associated with promoter region methylation without coding region mutation.
    Pogribny IP; James SJ
    Cancer Lett; 2002 Feb; 176(2):169-74. PubMed ID: 11804744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.
    Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C
    Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression but lack of mutation and methylation of p73 in hepatocellular carcinoma.
    Pan H; Liao SJ; Lai WY; Lu HC; Hsiao KM
    Acta Oncol; 2002; 41(6):550-5. PubMed ID: 12546528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of transforming growth factor beta type II receptor, Smad2, and Smad4 in hepatocellular carcinoma.
    Kawate S; Takenoshita S; Ohwada S; Mogi A; Fukusato T; Makita F; Kuwano H; Morishita Y
    Int J Oncol; 1999 Jan; 14(1):127-31. PubMed ID: 9863018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutation analysis of the tumor suppressor gene PTEN/MMAC1/TEP1 in human hepatocellular carcinoma].
    Zhang LN; Zha XL; Yu Q; He JY
    Shi Yan Sheng Wu Xue Bao; 2000 Sep; 33(3):223-7. PubMed ID: 12549040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
    Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
    Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and functional analysis of human p51, which structurally and functionally resembles p53.
    Osada M; Ohba M; Kawahara C; Ishioka C; Kanamaru R; Katoh I; Ikawa Y; Nimura Y; Nakagawara A; Obinata M; Ikawa S
    Nat Med; 1998 Jul; 4(7):839-43. PubMed ID: 9662378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA.
    Kang MS; Lee HJ; Lee JH; Ku JL; Lee KP; Kelley MJ; Won YJ; Kim ST; Park JG
    Int J Cancer; 1996 Sep; 67(6):898-902. PubMed ID: 8824565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA variants of DLC-1, a candidate tumor suppressor gene in human hepatocellular carcinoma.
    Park SW; Durkin ME; Thorgeirsson SS; Popescu NC
    Int J Oncol; 2003 Jul; 23(1):133-7. PubMed ID: 12792785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53CP is p51/p63, the third member of the p53 gene family: partial purification and characterization.
    Tan M; Bian J; Guan K; Sun Y
    Carcinogenesis; 2001 Feb; 22(2):295-300. PubMed ID: 11181451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of the Smad6 and Smad7 genes in hepatocellular carcinoma.
    Kawate S; Ohwada S; Hamada K; Koyama T; Takenoshita S; Morishita Y; Hagiwara K
    Int J Mol Med; 2001 Jul; 8(1):49-52. PubMed ID: 11408948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.
    Liu H; Wang Y; Zhou Q; Gui SY; Li X
    World J Gastroenterol; 2002 Jun; 8(3):480-2. PubMed ID: 12046074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.